Probing Transcriptional Activation at the Molecular Level
在分子水平上探测转录激活
基本信息
- 批准号:7466227
- 负责人:
- 金额:$ 25.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-04-01 至 2012-04-30
- 项目状态:已结题
- 来源:
- 关键词:Activator AppliancesAddressAffinityAmino AcidsBindingBinding SitesBiochemicalBiochemical GeneticsChemicalsChromatinClassCommunicable DiseasesCommunitiesComplexConflict (Psychology)CoupledCuesDNA BindingDataDevelopmentDisputesDissociationEquilibriumEukaryotaEukaryotic CellEventFormaldehydeFreezingFundingGenesGeneticGenetic TranscriptionIn VitroIndividualLightLinkLocationMalignant NeoplasmsMapsMeasuresMediator of activation proteinMetabolic DiseasesModelingMolecularMutagenesisPatternPlasmidsProcessed GenesProtein BindingProteinsPublic HealthRNA Polymerase IIRateRecruitment ActivityReporter GenesReportingResearchResolutionRoleSaccharomyces cerevisiaeSeriesSignal TransductionSpecificitySystemTP53 geneTertiary Protein StructureTestingTherapeuticTherapeutic AgentsThermodynamicsTimeTimeLineTranscription CoactivatorTranscriptional ActivationTranscriptional RegulationUp-RegulationVP 16Western Blottingbasechromatin immunoprecipitationcovalent bondcrosslinkdesignhuman NCYM proteinhuman diseasein vivoinhibitor/antagonistirradiationpromoterprotein protein interactionresearch studyresponsesmall molecule
项目摘要
DESCRIPTION (provided by applicant): The broad objective of the proposed research is to obtain a molecular-level understanding of the interactions between transcriptional activators and their target proteins within the transcriptional machinery using a suite of chemical approaches. Misregulation of transcription is either a cause or an effect of human diseases such as cancer, metabolic disorders, and infectious diseases. Thus, molecules that inhibit or promote the protein-protein interactions that regulate transcription are highly desirable both as mechanistic probes and, in the long term, as therapeutic agents that correct transcriptional errors. Only a handful of such molecules have been reported, however, due in part to the still-limited understanding of the mechanism of transcriptional regulation. In the case of transcriptional activators, proteins that activate the transcription of particular genes in a signal- responsive fashion, little conclusive is known about either the interaction partners within the transcriptional machinery or the functionally relevant thermodynamic parameters. As part of Specific Aim 1, we will kinetically characterize the interactions between several transcriptional activators and their target proteins in order to parse the connection between levels of gene up-regulation and the rates of association and dissociation of activator-transcriptional machinery protein complexes. In Specific Aims 2 and 3 in vivo (S. cerevisiae) crosslinking experiments along with FT-ICR mass spectrometric analysis of crosslinking products will be employed to identify the physiologically relevant targets of transcriptional activators, thus addressing a long-standing and fundamental mechanistic question in eukaryotic transcription. Taken together, the data generated through these experiments will provide a high resolution map of what and where transcriptional activators bind in the transcriptional machinery as they initiate gene up-regulation. This information will be enormously enabling for the discovery of transcription-targeting small molecules and, longer term, for the development of small molecules that target individual transcriptional activator-transcriptional machinery protein interactions implicated in human disease. PUBLIC HEALTH RELEVANCE: The experiments outlined in this proposal will provide a detailed picture of the binding profile of transcriptional activators and the contribution that the individual binding events make to transcriptional regulation. These data will make it possible to design more effective screens of small molecules that function as activators or inhibitors of transcription and, further, will provide a strategy by which specificity can be quickly evaluated. Ultimately, this will facilitate the discovery and development of transcription-based therapeutics.
描述(由申请人提供):拟议研究的广泛目标是使用一套化学方法获得对转录机器内转录激活剂与其靶蛋白之间相互作用的分子水平理解。转录失调既可能是癌症、代谢紊乱和传染病等人类疾病的原因,也可能是其结果。因此,抑制或促进调节转录的蛋白质-蛋白质相互作用的分子作为机制探针以及从长远来看作为纠正转录错误的治疗剂是非常理想的。然而,仅报道了少数此类分子,部分原因是对转录调控机制的了解仍然有限。就转录激活剂而言,蛋白质以信号响应方式激活特定基因的转录,但对于转录机制内的相互作用伙伴或功能相关的热力学参数知之甚少。作为具体目标 1 的一部分,我们将从动力学上表征几种转录激活因子与其靶蛋白之间的相互作用,以便解析基因上调水平与激活因子-转录机器蛋白复合物的结合和解离速率之间的联系。在具体目标 2 和 3 中,体内(酿酒酵母)交联实验以及交联产物的 FT-ICR 质谱分析将用于识别转录激活剂的生理相关靶标,从而解决长期存在的基本机制问题。真核转录。总而言之,通过这些实验生成的数据将提供高分辨率图谱,显示转录激活剂在启动基因上调时在转录机制中结合的内容和位置。这些信息将极大地促进转录靶向小分子的发现,从长远来看,有助于开发针对与人类疾病有关的个体转录激活因子-转录机器蛋白相互作用的小分子。公共健康相关性:本提案中概述的实验将提供转录激活因子的结合概况以及各个结合事件对转录调控的贡献的详细信息。这些数据将使得设计更有效的小分子筛选成为可能,这些小分子充当转录激活剂或抑制剂,并且进一步提供一种可以快速评估特异性的策略。最终,这将促进基于转录的疗法的发现和开发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANNA K. MAPP其他文献
ANNA K. MAPP的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANNA K. MAPP', 18)}}的其他基金
Probing transcriptional activation at the molecular level
在分子水平上探测转录激活
- 批准号:
10594975 - 财政年份:2020
- 资助金额:
$ 25.85万 - 项目类别:
Probing transcriptional activation at the molecular level
在分子水平上探测转录激活
- 批准号:
10370326 - 财政年份:2020
- 资助金额:
$ 25.85万 - 项目类别:
Probing transcriptional activation at the molecular level - Equipment Supplement
在分子水平上探测转录激活 - 设备补充
- 批准号:
10604581 - 财政年份:2020
- 资助金额:
$ 25.85万 - 项目类别:
Probing Transcriptional Activation at the Molecular Level
在分子水平上探测转录激活
- 批准号:
8111363 - 财政年份:2010
- 资助金额:
$ 25.85万 - 项目类别:
Small Molecule Inhibitors of the Transcriptional Activators ESX and NF-kB
转录激活剂 ESX 和 NF-kB 的小分子抑制剂
- 批准号:
8032426 - 财政年份:2009
- 资助金额:
$ 25.85万 - 项目类别:
Small Molecule Inhibitors of the Transcriptional Activators ESX and NF-kB
转录激活剂 ESX 和 NF-kB 的小分子抑制剂
- 批准号:
8223254 - 财政年份:2009
- 资助金额:
$ 25.85万 - 项目类别:
Small Molecule Inhibitors of the Transcriptional Activators ESX and NF-kB
转录激活剂 ESX 和 NF-kB 的小分子抑制剂
- 批准号:
8444638 - 财政年份:2009
- 资助金额:
$ 25.85万 - 项目类别:
Small Molecule Inhibitors of the Transcriptional Activators ESX and NF-kB
转录激活剂 ESX 和 NF-kB 的小分子抑制剂
- 批准号:
7699051 - 财政年份:2009
- 资助金额:
$ 25.85万 - 项目类别:
Chemical Tools for Regulating Eukaryotic Transcription
调节真核转录的化学工具
- 批准号:
6464312 - 财政年份:2002
- 资助金额:
$ 25.85万 - 项目类别:
Probing Transcriptional Activation at the Molecular Level
在分子水平上探测转录激活
- 批准号:
8964620 - 财政年份:2002
- 资助金额:
$ 25.85万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Predicting Tissue Specific Gli3 Regulatory Activity Using Hand2
使用 Hand2 预测组织特异性 Gli3 调节活动
- 批准号:
10647737 - 财政年份:2022
- 资助金额:
$ 25.85万 - 项目类别:
Pharmacologic Lysosomal Flux Activators to Ameliorate Alzheimer's Disease and Related Dementias
药理学溶酶体通量激活剂可改善阿尔茨海默病和相关痴呆症
- 批准号:
10281046 - 财政年份:2021
- 资助金额:
$ 25.85万 - 项目类别:
Discovering small molecules activators of stress responsive signaling
发现应激反应信号传导的小分子激活剂
- 批准号:
8624805 - 财政年份:2013
- 资助金额:
$ 25.85万 - 项目类别:
Discovering small molecules activators of stress responsive signaling
发现应激反应信号传导的小分子激活剂
- 批准号:
9050601 - 财政年份:2013
- 资助金额:
$ 25.85万 - 项目类别:
Discovering small molecules activators of stress responsive signaling
发现应激反应信号传导的小分子激活剂
- 批准号:
8828534 - 财政年份:2013
- 资助金额:
$ 25.85万 - 项目类别: